Morinaga&Co (2201) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
15 Oct, 2026Executive summary
H1 FY2026 net sales rose 2.5% YoY to ¥121.869bn, while operating income fell 3.7% to ¥13.350bn amid higher input and logistics costs and investment spending.
Confectionery & Foodstuffs and Frozen Desserts led segment growth; the in- and U.S. businesses recorded lower sales and operating income.
Revised FY2026 guidance targets ¥236.0bn sales and ¥22.3bn operating income, with lower sales guidance but higher profit forecasts.
Financial highlights
H1 net sales were ¥121,869m, up 2.5% YoY; gross profit was ¥49,916m, up 2.6%, with gross margin unchanged at 41.0%.
Operating income was ¥13,350m, down 3.7%, and operating margin was 11.0% versus 11.7% YoY; ordinary income fell 4.6% to ¥13,447m.
Profit attributable to owners of parent rose 3.8% to ¥11,031m; extraordinary income included a ¥1,986m gain on sales of investment securities.
Outlook and guidance
FY2026 forecast: net sales ¥236.0bn, operating income ¥22.3bn, ordinary income ¥22.5bn and parent-attributable profit ¥18.2bn.
Sales guidance was reduced by ¥4.0bn from ¥240.0bn; operating income, ordinary income and parent-attributable profit forecasts rose by ¥0.9bn, ¥0.8bn and ¥0.4bn, respectively.
H2 forecast: sales ¥114.13bn and operating income ¥8.949bn; the operating-income plan assumes ¥4.37bn from higher sales and ¥0.53bn from price revisions, partly offset by costs.
FY2026 year-end dividend forecast remains ¥32.50 per share; H1 interim dividend was ¥60.00 per share.
Latest events from Morinaga&Co
- Q1 earnings rose on U.S. growth and price revisions; FY2024 guidance was unchanged.2201
Q1 2024 - Record first-half sales lifted guidance, while second-half investment is expected to weigh on profit.2201
Q2 2024 - Record 9M sales and higher margins lifted full-year forecasts and the dividend.2201
Q3 2024 - Record FY2023 sales and profit growth, with FY2024 growth forecast amid cost headwinds.2201
Q4 2024 - Q1 sales rose 11.4%; a US$136 million U.S. factory will expand HI-CHEW capacity.2201
Q1 2025 - Record H1 sales and higher FY2025 guidance despite cost-pressured operating income.2201
Q2 2025 - 9M sales grew 7.8%, but raw-material inflation pressured earnings; FY2025 forecasts held.2201
Q3 2025 - FY2025 sales hit a record, while cacao inflation and cash outflows tempered gains.2201
Q4 2025 - Core sweets growth and MyMo expansion offset by near-term acquisition costs.2201
Q4 2026